Cargando…

Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma

OBJECTIVE: The incidence of non-virus-related hepatocellular carcinoma (NV-HCC) in hepatocellular carcinoma (HCC) is steadily increasing. The aim of this study was to establish a prognostic model to evaluate the overall survival (OS) of NV-HCC patients. METHODS: Overall, 261 patients with NV-HCC wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yu, Chen, Shulin, Wu, Yaxian, Qu, Yuanye, Jia, Lina, Xu, Qingxia, Dai, Shuqin, Xue, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528074/ https://www.ncbi.nlm.nih.gov/pubmed/36184588 http://dx.doi.org/10.1186/s12935-022-02725-5

Ejemplares similares

A novel clinical model for predicting malignancy of solitary pulmonary nodules: a multicenter study in chinese population
por: He, Xia, et al.
Publicado: (2021)

Establishment and Validation of Nomogram Model Integrated With Inflammation-Based Factors for the Prognosis of Advanced Non-Small Cell Lung Cancer
por: Huang, Zhiliang, et al.
Publicado: (2020)

Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma
por: Wang, Xueping, et al.
Publicado: (2019)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022)

Development and validation of a risk prediction score for patients with nasopharyngeal carcinoma
por: Xue, Ning, et al.
Publicado: (2021)

Establishment and Validation of a Peroxisome-related Gene Signature for Prognostic Prediction and Immune Distinction in Hepatocellular Carcinoma
por: Miao, Dan, et al.
Publicado: (2022)

Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model
por: Dai, Lei, et al.
Publicado: (2022)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma
por: Mao, Minjie, et al.
Publicado: (2020)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma
por: Li, Yinfang, et al.
Publicado: (2021)

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC
por: Yao, Wang, et al.
Publicado: (2023)

Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma
por: Shi, Haoting, et al.
Publicado: (2023)

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients
por: Mao, Minjie, et al.
Publicado: (2018)

Establishment of a pattern recognition metabolomics model for the diagnosis of hepatocellular carcinoma
por: Zhou, Peng-Cheng, et al.
Publicado: (2020)

Establishment and validation of a prognostic pomogram in unresectable hepatocellular carcinoma treated with intensity modulated radiotherapy: a real world study
por: Long, Meiying, et al.
Publicado: (2023)

Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes
por: Shi, Qingmiao, et al.
Publicado: (2023)

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021)

Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma
por: Li, Ganxun, et al.
Publicado: (2019)

Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
por: Wang, Zheng, et al.
Publicado: (2020)

Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma
por: Wang, Wen-Jie, et al.
Publicado: (2020)

Identification and Validation of Prognosis-Related Necroptosis Genes for Prognostic Prediction in Hepatocellular Carcinoma
por: Gao, Xin, et al.
Publicado: (2022)

Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
por: Xia, Xinxin, et al.
Publicado: (2021)

Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients
por: Liu, Miaoxia, et al.
Publicado: (2020)

Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection
por: Xu, Yang, et al.
Publicado: (2023)

Quantitative analysis of APC promoter methylation in hepatocellular carcinoma and its prognostic implications
por: XU, BAIYING, et al.
Publicado: (2014)

Development and validation of a coagulation-related genes prognostic model for hepatocellular carcinoma
por: Yang, Wan-Xia, et al.
Publicado: (2023)

Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Bioinformatics and the Role of NR6A1 in the Progression of HCC
por: Lin, Zhong-Hua, et al.
Publicado: (2022)

Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes
por: Wang, Lei, et al.
Publicado: (2022)

GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation
por: Liang, Xuexia, et al.
Publicado: (2023)

Establishment and Validation of a Nomogram Prognostic Model for Epithelioid Hemangioendothelioma
por: Li, Yujun, et al.
Publicado: (2022)

Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
por: Liu, Yankuo, et al.
Publicado: (2023)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy
por: Liao, Rui, et al.
Publicado: (2018)

Establishment of a Disease-Specific Graded Prognostic Assessment for Hepatocellular Carcinoma Patients with Spinal Metastasis
por: Rim, Chai Hong, et al.
Publicado: (2017)

Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram
por: Wang, Shuai, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis and Validation of the Prognostic Value of RBM10 Expression in Hepatocellular Carcinoma
por: Pang, Shu-Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k0k2akosnd7ushdsvsl8fd8dqd